These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18656931)

  • 1. A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase.
    Cheng HL; Huang HK; Chang CI; Tsai CP; Chou CH
    J Agric Food Chem; 2008 Aug; 56(16):6835-43. PubMed ID: 18656931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does bitter melon contain an activator of AMP-activated kinase?
    McCarty MF
    Med Hypotheses; 2004; 63(2):340-3. PubMed ID: 15236800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway.
    Tan MJ; Ye JM; Turner N; Hohnen-Behrens C; Ke CQ; Tang CP; Chen T; Weiss HC; Gesing ER; Rowland A; James DE; Ye Y
    Chem Biol; 2008 Mar; 15(3):263-73. PubMed ID: 18355726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EMCD, a hypoglycemic triterpene isolated from Momordica charantia wild variant, attenuates TNF-α-induced inflammation in FL83B cells in an AMP-activated protein kinase-independent manner.
    Cheng HL; Kuo CY; Liao YW; Lin CC
    Eur J Pharmacol; 2012 Aug; 689(1-3):241-8. PubMed ID: 22683870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fruit extracts of Momordica charantia potentiate glucose uptake and up-regulate Glut-4, PPAR gamma and PI3K.
    Kumar R; Balaji S; Uma TS; Sehgal PK
    J Ethnopharmacol; 2009 Dec; 126(3):533-7. PubMed ID: 19744549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
    Shih CC; Lin CH; Lin WL; Wu JB
    J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic potentials of Momordica charantia: multiple mechanisms behind the effects.
    Chaturvedi P
    J Med Food; 2012 Feb; 15(2):101-7. PubMed ID: 22191631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cucurbitane Triterpenoids from the Fruits of Momordica Charantia Improve Insulin Sensitivity and Glucose Homeostasis in Streptozotocin-Induced Diabetic Mice.
    Han JH; Tuan NQ; Park MH; Quan KT; Oh J; Heo KS; Na M; Myung CS
    Mol Nutr Food Res; 2018 Apr; 62(7):e1700769. PubMed ID: 29405623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [From cancer to diabetes treatment : the tumor suppressor LKB1 as a new pharmacological target].
    Foretz M; Guigas B; Viollet B
    Med Sci (Paris); 2006 Apr; 22(4):348-50. PubMed ID: 16597397
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of glycerol-3-phosphate acyltransferase as a potential treatment for insulin resistance and type 2 diabetes.
    Thuresson ER
    Curr Opin Investig Drugs; 2004 Apr; 5(4):411-8. PubMed ID: 15134282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypogylcemic activity of aqueous extract of some indigenous plants.
    Khan B; Arayne MS; Naz S; Mukhtar N
    Pak J Pharm Sci; 2005 Jan; 18(1):62-4. PubMed ID: 16431387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cucurbitane-type triterpenoids from the stems of momordica charantia.
    Chang CI; Chen CR; Liao YW; Cheng HL; Chen YC; Chou CH
    J Nat Prod; 2008 Aug; 71(8):1327-30. PubMed ID: 18637688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cucurbitane-type triterpenoids from Momordica charantia.
    Chang CI; Chen CR; Liao YW; Cheng HL; Chen YC; Chou CH
    J Nat Prod; 2006 Aug; 69(8):1168-71. PubMed ID: 16933869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological actions and potential uses of Momordica charantia: a review.
    Grover JK; Yadav SP
    J Ethnopharmacol; 2004 Jul; 93(1):123-32. PubMed ID: 15182917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetyl-l-carnitine inhibits TNF-alpha-induced insulin resistance via AMPK pathway in rat skeletal muscle cells.
    Zhang Z; Zhao M; Li Q; Zhao H; Wang J; Li Y
    FEBS Lett; 2009 Jan; 583(2):470-4. PubMed ID: 19121314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicine. Cancer-suppressing enzyme adds a link to type 2 diabetes.
    Marx J
    Science; 2005 Nov; 310(5752):1259. PubMed ID: 16311305
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study on hypoglycemic action and active constituents of Momordica charantia L].
    Lu L; Zhao Y
    Zhong Yao Cai; 2002 Jun; 25(6):449-51. PubMed ID: 14968781
    [No Abstract]   [Full Text] [Related]  

  • 18. Momordica charantia and its novel polypeptide regulate glucose homeostasis in mice via binding to insulin receptor.
    Lo HY; Ho TY; Lin C; Li CC; Hsiang CY
    J Agric Food Chem; 2013 Mar; 61(10):2461-8. PubMed ID: 23414136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nutritional support on glucose control.
    Seematter G; Tappy L
    Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):210-4. PubMed ID: 17285012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro hypoglycemic activity of methanolic extract of some indigenous plants.
    Arayne MS; Sultana N; Mirza AZ; Zuberi MH; Siddiqui FA
    Pak J Pharm Sci; 2007 Oct; 20(4):268-73. PubMed ID: 17604247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.